Innoprot is a leading biotechnology company specializing in the development of innovative cell-based assays, high-content screening (HCS) technologies, and custom screening services for drug discovery. By offering advanced in vitro cellular models—particularly in neurobiology and oncology—Innoprot helps pharmaceutical companies accurately identify promising hits and evaluate drug efficacy early.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.